Specialty growth and new deals lift the first-half outlook.
MCK McKesson Corporation
XNYS
1090.01
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
MCK
$1090.01
—
Key stats
$1090.01
- 52-Week Range
- $723.68 – $1121.50
- YTD
- +32.37%
- IV Rank (30D)
- 34.99
- Straddle Price
- $84.50
- P/C Vol Ratio
- 0.91
- Market Cap
- $124.7B
- Open
- $1085.84
- Day Range
- $1073.43 – $1121.50
- Volume
- 556,231
- Prev Close
- $1069.44
Fair Value
+50.0% vs price
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.91% |
| Beta vs SPY | 0.55 |
| Cost of Equity (CAPM) | 7.66% (VRP-adj) |
| WACC | 7.58% |
| Volatility Risk Premium | +22.4pp (IV − HV30) |
| Effective Tax Rate | 17.9% |
| Rev. Growth (YoY, DCF input) | +2.2% |
| DCF Horizon | 5 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.02 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $6.4B |
| Return on Equity (TTM) | -108.3% |
| Book / Price | -2.9% |
| Gross Margin (TTM) | 3.6% |
| FCF Margin (TTM) | 1.6% |
| Quality Score | 0/6 — cyclical/struggling (5y DCF) |
| Market-Implied Growth | +3.4% (reverse-DCF on current price) |
| SMA 50 | $930.78 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $989.96 |
| Bollinger Width / SMA20 | 1.3% (drives anchor stability) |
| Net Debt | $3.3B |
| Market Cap | $131B |
Peers used for multiples: AAPL, AMZN, AVGO, GOOGL, JNJ, LLY, MSFT, NVDA
Blended Fair Value
$3861.72
Deviation
+50.0%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $1013.15 | 20% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $1231.09 | 5% | median 32.4× · 8 peers |
| Peer EV/EBITDA | $1389.49 | 6% | median 22.5× · 8 peers |
| Peer P/B | n/a | 0% | median 12.1× · 8 peers |
| Peer P/S | $36863.54 | 8% | median 10.8× · 8 peers |
| Market Anchor (SMA50) | $930.78 | 41% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | $1074.48 | 20% | 35 strikes · skew +0.37 |
As of 2026-11-05 · updated
Related
About
- Industry (SIC)
- WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES (5122) · industry map
- Exchange
- XNYS
- Market Cap
- $124.7B
- Employees
- 43,000
- List Date
- 1987-08-03
- CIK
- 0000927653
- Headquarters
- Irving, TX
- Homepage
- https://www.mckesson.com
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a vari…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 0.02% | 3.47% | 1.16% | 5.59% | 5.04% | 0.94% | 2.70% |
| Feb | -5.68% | 7.02% | -5.71% | 3.90% | 6.74% | 16.64% | 3.82% |
| Mar | 12.25% | 12.65% | 1.22% | 2.09% | 4.42% | -12.67% | 3.33% |
| Apr | -3.10% | 0.85% | 0.13% | 0.13% | 5.80% | -6.55% | -0.46% |
| May | 0.14% | 7.13% | 10.40% | 7.25% | 1.80% | -8.79% | 2.99% |
| Jun | -0.31% | 1.24% | 9.78% | 1.90% | 1.53% | 2.83% | 2.83% |
| Jul | 5.79% | 3.66% | -4.37% | 5.23% | -4.70% | 11.04% | 2.77% |
| Aug | 0.28% | 7.18% | 1.80% | -10.81% | -1.74% | 7.03% | 0.62% |
| Sep | -1.78% | -6.59% | 5.46% | -13.86% | 11.70% | -5.84% | -1.82% |
| Oct | 3.93% | 12.29% | 4.10% | 0.42% | 6.05% | 10.65% | 6.24% |
| Nov | 4.17% | -0.09% | 2.39% | 19.41% | 7.42% | 9.48%* | 7.13% |
| Dec | 15.39% | -1.21% | -0.36% | -8.27% | -4.27% | -- | 0.26% |
| Total | 33.34% | 56.94% | 27.75% | 8.99% | 46.04% | 22.17% | 32.54% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $997.98
SMA 50: $934.66
SMA 200: $866.79
Current: $1090.53
EMA 12: $1013.74
EMA 26: $982.14
MACD: 31.6036 | Signal: 5.4285
BULLISH
ADX (14): 28.25
TREND
+DI: 48.80
−DI: 15.03
Momentum Oscillators
RSI (14): 76.43
OVERBOUGHT
Stoch %K: 79.18
Stoch %D: 69.20
Williams %R: -18.50
Volume & Volatility
BB Upper: $1068.92
BB Lower: $927.04
OVERBOUGHT
OBV: 19,827,583
Vol SMA 20: 702,515
Vol ROC: -12.68%
ATR: $28.48
True Range: $52.06
HV 20: 30.7%
HV 30: 30.3%
HV 60: 28.8%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-06T00:00:00 – 2026-11-04T00:00:00
AI Analysis
LLM Stock Analysis Report
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers:
- Recent positive news sentiment from biopharmaceutical research reports
- Low volatility, indicating low risk relative to market
- Strong support levels around $809.01, a key level to monitor
Primary Risks:
- Bearish MACD signal and histogram indicate potential further decline
- Oversold RSI reading at 29.45 may trigger a short-term bounce
- Options market pricing a moderate move by expiration, indicating caution
Investment Thesis: MCK's recent news sentiment is positive, driven by biopharmaceutical research reports. The stock has low volatility, indicating a relatively stable environment. While there are bearish technical signals present, the options market suggests a moderate move by expiration, which may indicate a potential bounce.
Recent News Sentiment Impact: The recent positive news headlines have likely contributed to the recent price movement and stabilization of the stock. However, it is essential to consider the potential impact of future earnings announcements and other events on the stock's performance.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): BEARISH
- Medium-term (1-3 months): NEUTRAL
- Long-term (3-12 months): BULLISH
Support/Resistance Levels:
- Key price levels from moving averages:
- SMA 20: $847.90
- SMA 50: $893.57
- SMA 200: $812.76
- Technical patterns:
- Upper Bollinger Band: $886.79
Momentum Signals:
- RSI interpretation: Oversold at 29.45 (potential buy signal)
- MACD signal: Bearish crossover, indicating potential further decline
- Bollinger Bands position: Neutral, indicating mean reversion potential
Volume Analysis:
- Volume trends:
- Downward volume trend in recent days, potentially indicating selling pressure
- Institutional interest signals:
- Low institutional activity, suggesting caution
News & Sentiment Analysis
Recent Headlines Summary:
The recent news headlines have been positive, driven by biopharmaceutical research reports. The sentiment has been generally optimistic, with most articles highlighting the potential for growth and stability.
Sentiment Assessment:
Aggregate news sentiment is POSITIVE (4/5), suggesting a favorable environment for the stock.
Catalyst Identification:
No specific catalysts have been identified in recent headlines, but upcoming earnings announcements could potentially impact the stock's performance.
Risk & Volatility Assessment
Beta Interpretation:
Beta is 0.04, indicating low volatility relative to market (low risk).
Volatility Regime:
Current volatility regime is LOW, with a historical volatility of 17.4% (HV20) and 17.0% (HV30).
Options Market Signals:
- IV rank: High at 90.7%
- Put/call ratio: Bearish at 2.09
- Unusual activity: None noted
Market Context & Positioning
Sector Performance:
MCK is performing relatively well within its sector, with a strong trend in place.
Institutional Activity:
Low institutional activity suggests caution and potential bearish sentiment.
Correlation Analysis:
The stock has a low correlation coefficient (0.02) with the market, indicating limited market influence.
Key Levels & Action Items
Critical Price Levels:
- Support level at $809.01
- Resistance level at $886.79
Breakout/Breakdown Levels:
- Breakout level at $893.57
- Breakdown level at $812.76
Time-Sensitive Catalysts:
No specific time-sensitive catalysts have been identified.
Risk Management:
Stop-loss levels should be set around the support level at $809.01, and position sizing considerations should prioritize caution due to bearish technical signals.
Please note that this report is based on the provided data and may not reflect actual market conditions or events.
Generated
News
All MCK news →
Drug distributors went three-for-three, with Cardinal Health putting up the last fall-quarter beat on Thursday, following the examples set by McKesson and Cencora. The post Drug Wholesalers Go Three-For-Three In Earnings Beats, But Only Two Stocks Pop appeared first on…
McKesson stock was flat late Wednesday, though the drug wholesaler topped fiscal second-quarter views and hiked its earnings guide. The post The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know appeared first on Investor's Business Daily .
Showing 1–10 of 15
Page 1 of 2
Earnings History
13 of 23 under expected move
Avg Expected Move
4.91%
Avg Actual Move
4.35%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-02 | After-Close | 3.06% | 0.53% | 0.17x | Within |
| 2021-05-06 | After-Close | 3.46% | 6.76% | 1.95x | Exceeded |
| 2021-08-04 | After-Close | 3.69% | 2.78% | 0.75x | Within |
| 2021-11-01 | After-Close | 4.62% | 5.21% | 1.13x | Exceeded |
| 2022-02-02 | After-Close | 3.91% | 3.47% | 0.89x | Within |
| 2022-05-05 | After-Close | 4.01% | 5.95% | 1.48x | Exceeded |
| 2022-08-03 | After-Close | 3.93% | 3.27% | 0.83x | Within |
| 2022-11-01 | After-Close | 4.74% | 2.03% | 0.43x | Within |
| 2023-02-01 | After-Close | 3.59% | 1.21% | 0.34x | Within |
| 2023-05-08 | After-Close | 4.27% | 5.47% | 1.28x | Exceeded |
| 2023-08-02 | After-Close | 4.62% | 5.34% | 1.16x | Exceeded |
| 2023-11-01 | After-Close | 4.54% | 2.61% | 0.57x | Within |
| 2024-02-07 | After-Close | 4.29% | 4.40% | 1.03x | Exceeded |
| 2024-05-07 | After-Close | 4.35% | 0.39% | 0.09x | Within |
| 2024-08-07 | After-Close | 7.26% | 11.34% | 1.56x | Exceeded |
| 2024-11-06 | After-Close | 7.62% | 10.60% | 1.39x | Exceeded |
| 2025-02-05 | After-Close | 6.61% | 1.18% | 0.18x | Within |
| 2025-05-08 | After-Close | 5.69% | 0.47% | 0.08x | Within |
| 2025-08-06 | After-Close | 4.67% | 5.76% | 1.23x | Exceeded |
| 2025-11-05 | After-Close | 3.98% | 1.70% | 0.43x | Within |
| 2026-02-04 | After-Close | 5.26% | 16.52% | 3.14x | Exceeded |
| 2026-05-07 | After-Close | 7.15% | 2.47% | 0.35x | Within |
| 2026-08-05 | After-Close | 7.54% | 0.67% | 0.09x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
MCK Options Activity & IV Rank
MCK IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 29.0%
7-DTE IV: 31.2%
Expected Move: $84.50
7-DTE Move: $56.00
Days to Exp: 43 (2026-12-18)
Options Flow
Call Volume: 432
Put Volume: 395
P/C Volume: 0.914
NEUTRAL
Call OI: 2,456
Put OI: 1,993
P/C OI: 0.811
Total OI: 4,449
ATM Options Pricing
ATM Call: $46.05
ATM Put: $38.45
Call %: 4.2%
Put %: 3.5%
Chain Summary
Chain Volume: 6,066
Chain OI: 23,714
Last Updated: 11/5/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
HIGH γ vs HISTORY
Estimated net dealer gamma is at the 97th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
97%
vs own history
GEX tilt
+0.73
OI-weighted, today
Vanna tilt
-0.33
δ-sensitivity to IV
Charm tilt
+0.16
δ-decay vs time
Vanna tilt -0.33: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably if implied volatility changed.
? What is this?
· 86 ATM contracts, 6k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
23%
+3.8
pts
EXTREME
ATM 30.8% / Wing 34.6%
30 DTE / 10d
—
—
pts
EXTREME
No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)24.3LowNov 5
IV Rank (30 DTE)35.0MediumNov 5
Straddle Price (30 DTE)$84.50Nov 5
Beta Analysis
Risk Metrics
Beta: -0.2153
Alpha: 32.92%
Correlation: -0.0904
R-Squared: 0.8%
Stock Volatility: 31.8%
Market Volatility: 13.3%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Negative beta - stock moves opposite to market
Negative beta - stock moves opposite to market
Beta & Alpha Over Time
Notable investors who own MCK
7 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $347.9M | #84 of 6285 | +512.2% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $272.8M | #37 of 3138 | +208.0% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $76.4M | #430 of 3716 | +76.2% | 13F | |
| Point72 Hedge fund Steve Cohen | $54.4M | #306 of 1945 | new | 13F | |
| Bridgewater Associates Hedge fund Ray Dalio | $53.2M | #75 of 997 | +4.4% | 13F | |
| Lone Pine Capital Hedge fund Stephen Mandel | $43.7M | #32 of 34 | -85.3% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $15.3M | #572 of 4729 | -14.4% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
MCK Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 122,725,000 (as of 2026-06-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
34 filers$609.10M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Jane Street Group, LLC Custodian | $141.15M | 23.17% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $111.45M | 18.30% | 2026-06-30 |
| 3 | Citadel Advisors LLC Custodian | $106.84M | 17.54% | 2026-06-30 |
| 4 | Wolverine Trading, LLC Custodian | $37.33M | 6.13% | 2025-09-30 |
| 5 | Squarepoint Ops LLC | $36.27M | 5.95% | 2026-06-30 |
| 6 | Point72 Asset Management, L.P. | $29.62M | 4.86% | 2026-06-30 |
| 7 | Cubist Systematic Strategies, LLC | $28.74M | 4.72% | 2025-09-30 |
| 8 | Millennium Management LLC Custodian | $20.40M | 3.35% | 2026-06-30 |
| 9 | D. E. Shaw & Co., Inc. Custodian | $15.41M | 2.53% | 2026-06-30 |
| 10 | Twin Tree Management, LP | $14.89M | 2.44% | 2026-06-30 |
| 11 | Citigroup Inc. Custodian | $12.32M | 2.02% | 2026-06-30 |
| 12 | Delta Accumulation, LLC | $11.64M | 1.91% | 2026-06-30 |
| 13 | BNP Paribas Financial Markets Custodian | $6.27M | 1.03% | 2026-06-30 |
| 14 | Allianz Asset Management GmbH | $4.53M | 0.74% | 2026-06-30 |
| 15 | Oribel Capital Management, LP | $3.78M | 0.62% | 2026-06-30 |
| 16 | Balyasny Asset Management L.P. | $3.70M | 0.61% | 2026-06-30 |
| 17 | SIG BROKERAGE, LP | $3.25M | 0.53% | 2026-06-30 |
| 18 | TUDOR INVESTMENT CORP ET AL | $3.17M | 0.52% | 2026-06-30 |
| 19 | Two Sigma Investments, LP Custodian | $2.27M | 0.37% | 2026-06-30 |
| 20 | Marex Group Ltd | $2.12M | 0.35% | 2026-06-30 |
| 21 | Alphadyne Asset Management LP | $1.96M | 0.32% | 2026-06-30 |
| 22 | Verition Fund Management LLC | $1.81M | 0.30% | 2026-06-30 |
| 23 | PEAK6 LLC | $1.59M | 0.26% | 2026-06-30 |
| 24 | CAPSTONE INVESTMENT ADVISORS, LLC | $1.51M | 0.25% | 2026-06-30 |
| 25 | Qube Research & Technologies Ltd | $1.51M | 0.25% | 2026-06-30 |
31 filers$425.64M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $126.11M | 29.63% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $70.72M | 16.62% | 2026-06-30 |
| 3 | BNP Paribas Financial Markets Custodian | $53.65M | 12.60% | 2026-06-30 |
| 4 | Jane Street Group, LLC Custodian | $46.85M | 11.01% | 2026-06-30 |
| 5 | Wolverine Trading, LLC Custodian | $30.70M | 7.21% | 2025-09-30 |
| 6 | Cubist Systematic Strategies, LLC | $17.46M | 4.10% | 2025-09-30 |
| 7 | Millennium Management LLC Custodian | $15.19M | 3.57% | 2026-06-30 |
| 8 | Point72 Asset Management, L.P. | $14.43M | 3.39% | 2026-06-30 |
| 9 | CAPSTONE INVESTMENT ADVISORS, LLC | $12.24M | 2.88% | 2026-06-30 |
| 10 | Allianz Asset Management GmbH | $7.63M | 1.79% | 2026-06-30 |
| 11 | D. E. Shaw & Co., Inc. Custodian | $4.38M | 1.03% | 2026-06-30 |
| 12 | Lido Advisors, LLC | $3.55M | 0.83% | 2026-06-30 |
| 13 | Verition Fund Management LLC | $3.32M | 0.78% | 2026-06-30 |
| 14 | Soltis Investment Advisors LLC | $2.82M | 0.66% | 2026-09-30 |
| 15 | HSBC Holdings plc Custodian | $2.25M | 0.53% | 2026-06-30 |
| 16 | Squarepoint Ops LLC | $2.04M | 0.48% | 2026-06-30 |
| 17 | UBS Group AG Custodian | $1.89M | 0.44% | 2026-06-30 |
| 18 | PEAK6 LLC | $1.51M | 0.35% | 2026-06-30 |
| 19 | Twin Tree Management, LP | $1.36M | 0.32% | 2026-06-30 |
| 20 | Two Sigma Investments, LP Custodian | $1.13M | 0.27% | 2026-06-30 |
| 21 | Alphadyne Asset Management LP | $1.06M | 0.25% | 2026-06-30 |
| 22 | Qube Research & Technologies Ltd | $1.06M | 0.25% | 2026-06-30 |
| 23 | READYSTATE ASSET MANAGEMENT LP | $755.60K | 0.18% | 2026-06-30 |
| 24 | Banco BTG Pactual S.A. | $755.60K | 0.18% | 2026-06-30 |
| 25 | Walleye Capital LLC | $604.48K | 0.14% | 2026-06-30 |
MCK Insider Trading (Form 4)
Latest: 2026-10-19Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-19 | Francisco Fraga | EVP, CIO and CTO | Sell (S) | −800 | $995.80 | -$797.1K | EDGAR |
| 2026-09-10 | Napoleon B Rutledge JR | SVP, Controller & CAO | Sell (S) | −111 | $891.45 | -$99.0K | EDGAR |
| 2026-08-11 | Ramesh (NMN) Srinivasan | EVP and Chief Strategy Officer | Grant (A) | +368 RSU | — | EDGAR | |
| 2026-08-11 | Bradley E Lerman | Director | Sell (S) | −301 | $892.33 | -$268.6K | EDGAR |
| 2026-07-23 | James H. Hinton | Director | Grant (A) | +277 RSU | — | EDGAR | |
| 2026-07-23 | Dominic J Caruso | Director | Award (A) | +277 | $814.04 | $225.5K | EDGAR |
| 2026-07-23 | Deborah Dunsire | Director | Grant (A) | +277 RSU | — | EDGAR | |
| 2026-07-23 | Webster Roy Dunbar | Director | Grant (A) | +277 RSU | — | EDGAR | |
| 2026-07-23 | Kevin M Ozan | Director | Grant (A) | +277 RSU | — | EDGAR | |
| 2026-07-23 | Lynne M Doughtie | Director | Grant (A) | +277 RSU | — | EDGAR | |
| 2026-07-23 | Kathleen Wilson-Thompson | Director | Award (A) | +277 | $814.04 | $225.5K | EDGAR |
| 2026-07-23 | Bradley E Lerman | Director | Grant (A) | +277 RSU | — | EDGAR | |
| 2026-07-23 | Julie L. Gerberding | Director | Grant (A) | +277 RSU | — | EDGAR | |
| 2026-07-23 | Maria Martinez | Director | Award (A) | +277 | $814.04 | $225.5K | EDGAR |
| 2026-07-08 | Brian S. Tyler | Chief Executive Officer | Sell (S) | −8,463 | $793.56 | -$6.72M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
MCK Insider Holdings
11 insiders · @ $1090.53
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Britt J. Vitalone | EVP & CFO | 22,505 | $24.54M | -$43.87M | 42 | 2026-05-27 |
| 2 | Brian S. Tyler | Chief Executive Officer | 6,134 | $6.69M | -$212.52M | 101 | 2026-07-08 |
| 3 | Francisco Fraga | EVP, CIO and CTO | 5,423 | $5.91M | -$797.1K | 5 | 2026-10-19 |
| 4 | LeAnn B Smith | EVP & Chief HR Officer | 4,798 | $5.23M | -$4.93M | 25 | 2026-06-02 |
| 5 | Michele Lau | EVP and Chief Legal Officer | 3,386 | $3.69M | -$5.87M | 13 | 2026-05-27 |
| 6 | Thomas L Rodgers | EVP, Chief Strategy & BDO | 2,268 | $2.47M | -$12.23M | 32 | 2026-06-03 |
| 7 | Donald R Knauss | Director | 1,779 | $1.94M | $0 | 13 | 2025-07-31 |
| 8 | Dominic J Caruso | Director | 927 | $1.01M | $0 | 9 | 2026-07-23 |
| 9 | Kathleen Wilson-Thompson | Director | 578 | $630.3K | $0 | 6 | 2026-07-23 |
| 10 | Maria Martinez | Director | 578 | $630.3K | -$611.0K | 10 | 2026-07-23 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
MCK Board & Officers
As of SEC filings through Oct 19, 2026Directors 12
- Donald R Knauss · since Oct 20, 2014
- Bradley E Lerman · since Apr 24, 2018
- Dominic J Caruso · since Sep 12, 2018
- Maria Martinez · since Oct 18, 2019
- James H. Hinton · since Jan 13, 2022
- Kathleen Wilson-Thompson · since Jan 13, 2022
- Webster Roy Dunbar · since Apr 1, 2022
- Brian S. Tyler · listed since Sep 2023
- Kevin M Ozan · since Jan 8, 2024
- Deborah Dunsire · since Jun 3, 2024
- Julie L. Gerberding · since Feb 3, 2025
- Lynne M Doughtie · since Feb 3, 2025
Officers 8
- Brian S. Tyler · Chief Executive Officer · listed since May 2019
- Kenny K Cheung · EVP & CFO · since May 29, 2026
- Thomas L Rodgers · EVP, Chief Strategy & BDO · since Jun 5, 2020
- LeAnn B Smith · EVP & Chief HR Officer · since Dec 1, 2022
- Michele Lau · EVP and Chief Legal Officer · since Jan 1, 2024
- Ramesh (NMN) Srinivasan · EVP and Chief Strategy Officer · since Aug 1, 2026
- Francisco Fraga · EVP, CIO and CTO · since Apr 1, 2026
- Napoleon B Rutledge JR · SVP, Controller & CAO · since Mar 1, 2022
Changes in the last 10 years (41)
| Aug 1, 2026 | Ramesh (NMN) Srinivasan became EVP and Chief Strategy Officer |
| May 29, 2026 | Kenny K Cheung became EVP & CFO |
| Apr 1, 2026 | Francisco Fraga became EVP, CIO and CTO |
| Mar 3, 2026 | The company announced the departure of Britt J. Vitalone as EVP & CFO in an SEC filing |
| Feb 3, 2025 | Lynne M Doughtie became a director |
| Feb 3, 2025 | Julie L. Gerberding became a director |
| Jun 3, 2024 | Deborah Dunsire became a director |
| May 28, 2024 | The company announced the departure of Susan R Salka from the board in an SEC filing |
| May 28, 2024 | The company announced the departure of Linda Provie Mantia from the board in an SEC filing |
| Jan 8, 2024 | Kevin M Ozan became a director |
| Jan 1, 2024 | Michele Lau became EVP and Chief Legal Officer |
| Sep 29, 2023 | The company announced the departure of Nancy Avila as EVP, CIO & CTO in an SEC filing |
| Sep 7, 2023 | Brian S. Tyler first listed as a director in an SEC filing |
| Dec 1, 2022 | LeAnn B Smith became EVP & Chief HR Officer |
| Apr 1, 2022 | Webster Roy Dunbar became a director |
| Mar 1, 2022 | Napoleon B Rutledge JR became SVP, Controller & CAO |
| Jan 13, 2022 | Kathleen Wilson-Thompson became a director |
| Jan 13, 2022 | James H. Hinton became a director |
| Nov 4, 2021 | Brian S. Tyler no longer listed as a director in SEC filings |
| Sep 11, 2021 | Kevin Emerson became SVP, Controller & CAO |
| Sep 6, 2021 | Richard H Carmona became a director |
| May 11, 2021 | Lori A. Schechter no longer listed as a 10% owner in SEC filings |
| Oct 19, 2020 | Linda Provie Mantia became a director |
| Jun 5, 2020 | Thomas L Rodgers became EVP, Chief Strategy & BDO |
| May 26, 2020 | Lori A. Schechter first listed as a 10% owner in an SEC filing |
| Jan 13, 2020 | Nancy Avila became EVP, CIO & CTO |
| Nov 5, 2019 | Tracy Faber listed as EVP & Chief HR Officer (previously EVP, CHRO) in SEC filings |
| Oct 18, 2019 | Maria Martinez became a director |
| Oct 1, 2019 | Tracy Faber became EVP, CHRO |
| Sep 11, 2019 | Sundeep G. Reddy listed as SVP & Controller (previously SVP & Corporate Controller) in SEC filings |
| Sep 11, 2019 | Lori A. Schechter listed as EVP, Chief Legal Officer & GC (previously EVP, GC & Chief Compl. Officer) in SEC filings |
| Jul 1, 2019 | Kenneth E Washington became a director |
| May 23, 2019 | Brian S. Tyler listed as Chief Executive Officer (previously President & COO) in SEC filings |
| May 23, 2019 | Brian S. Tyler first listed as a director in an SEC filing |
| Nov 13, 2018 | Bansi Nagji listed as EVP, Chief Strategy & BD Off (previously EVP, Corp Strategy & Bus. Dev.) in SEC filings |
| Sep 12, 2018 | Dominic J Caruso became a director |
| Aug 3, 2018 | Brian S. Tyler listed as President & COO (previously EVP, Corp Strategy & Bus. Dev.) in SEC filings |
| Jul 25, 2018 | Sundeep G. Reddy became SVP & Corporate Controller |
| May 25, 2018 | Erin M Lampert listed as SVP & Chief Accounting Officer (previously SVP & Controller) in SEC filings |
| Apr 24, 2018 | Bradley E Lerman became a director |
| Jan 1, 2018 | Britt J. Vitalone became EVP & CFO |
Not reported recently (19)
- Richard H Carmona · Last reported as a director in an SEC filing dated Aug 1, 2024
- Lori A. Schechter · Last reported as EVP, Chief Legal Officer & GC in an SEC filing dated Jun 1, 2023
- Tracy Faber · Last reported as EVP & Chief HR Officer in an SEC filing dated Nov 10, 2022
- Kevin Emerson · Last reported as SVP, Controller & CAO in an SEC filing dated Feb 3, 2022
- Christine M Jacobs · Last reported as a director in an SEC filing dated Jul 26, 2021
- Marie L/ca Knowles · Last reported as a director in an SEC filing dated Jul 26, 2021
- Edward A Mueller · Last reported as a director in an SEC filing dated Jul 26, 2021
- Kenneth E Washington · Last reported as a director in an SEC filing dated Jul 26, 2021
- Sundeep G. Reddy · Last reported as SVP & Controller in an SEC filing dated Jun 16, 2021
- N Anthony Coles · Last reported as a director in an SEC filing dated Aug 19, 2020
- Kathleen D. McElligott · Last reported as EVP, CIO & CTO in an SEC filing dated May 31, 2019
- Bansi Nagji · Last reported as EVP, Chief Strategy & BD Off in an SEC filing dated May 28, 2019
- Jorge Figueredo · Last reported as EVP, Human Resources in an SEC filing dated May 23, 2019
- John H Hammergren · Last reported as a director in an SEC filing dated May 31, 2018
- Erin M Lampert · Last reported as SVP & Chief Accounting Officer in an SEC filing dated May 31, 2018
- Andy D Bryant · Last reported as a director in an SEC filing dated Jul 27, 2017
- Paul C Julian · Last reported as EVP, Group President in an SEC filing dated May 31, 2017
- James A Beer · Last reported as EVP & Chief Financial Officer in an SEC filing dated May 31, 2017
- Wayne A Budd · Last reported as a director in an SEC filing dated Dec 6, 2016
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
MCK Proposed Insider Sales (Form 144)
Latest: 2026-11-04
? Form 144 Guide
Last 30d:
2 filings
· $1.4M notice value
· Last 90d:
3 filings
· $1.7M notice value
· 2 unique filers
· 67% under 10b5-1 plans
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
Top 90-day filers:
Fraga Francisco (2, $1.4M) · Lerman Bradley E (1, $269K)
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-11-04 | Fraga Francisco | Officer | 600 | $630.0K | 2026-11-04 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-10-15 | Fraga Francisco | Officer | 801 | $797.1K | 2026-10-15 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-08-10 | Lerman Bradley E | Director | 301 | $268.6K | 2026-08-10 | RBC CAPITAL MARKETS LLC | — | EDGAR |
| 2026-08-03 | Vitalone Britt J. | Former Officer | 7,925 | $6.68M | 2026-08-03 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-07-07 | TYLER BRIAN S. | Officer, Director | 8,463 | $6.72M | 2026-07-07 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-06-17 | TYLER BRIAN S. | Officer, Director | 8,463 | $6.56M | 2026-06-17 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-06-09 | TYLER BRIAN S. | Officer, Director | 4,929 | $3.76M | 2026-06-09 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-06-02 | Rodgers Thomas L | Officer | 699 | $514.0K | 2026-06-02 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-06-01 | Rodgers Thomas L | Officer | 123 | $90.5K | 2026-06-01 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-06-01 | Smith LeAnn B | Officer | 1,810 | $1.33M | 2026-06-01 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-05-08
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-07 | 0000927653-26-000066 | EDGAR |
| 2026-04-28 | 0000927653-26-000053 | EDGAR |
| 2026-04-06 | 0000927653-26-000045 | EDGAR |
| 2026-03-06 | 0000927653-26-000038 | EDGAR |
| 2026-03-05 | 0000927653-26-000035 | EDGAR |
| 2026-02-04 | 0000927653-26-000015 | EDGAR |
| 2025-11-05 | 0000927653-25-000138 | EDGAR |
| 2025-09-23 | 0000927653-25-000125 | EDGAR |
| 2025-09-18 | 0000927653-25-000121 | EDGAR |
| 2025-08-06 | 0000927653-25-000105 | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-08 | 0000927653-26-000069 | EDGAR |
| 2025-05-09 | 0000927653-25-000036 | EDGAR |
| 2024-05-08 | 0000927653-24-000035 | EDGAR |
| 2023-05-09 | 0000927653-23-000038 | EDGAR |
| 2022-05-09 | 0000927653-22-000051 | EDGAR |
| 2021-05-12 | 0000927653-21-000039 | EDGAR |
| 2020-05-22 | 0000927653-20-000033 | EDGAR |
| 2019-05-15 | 0000927653-19-000009 | EDGAR |
| 2018-05-24 | 0000927653-18-000010 | EDGAR |
| 2017-05-22 | 0000927653-17-000007 | EDGAR |
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-02-04 | 0000927653-26-000017 | EDGAR |
| 2025-11-06 | 0000927653-25-000140 | EDGAR |
| 2025-08-06 | 0000927653-25-000107 | EDGAR |
| 2025-02-06 | 0000927653-25-000014 | EDGAR |
| 2024-11-07 | 0000927653-24-000125 | EDGAR |
| 2024-08-07 | 0000927653-24-000098 | EDGAR |
| 2024-02-08 | 0000927653-24-000021 | EDGAR |
| 2023-11-02 | 0000927653-23-000083 | EDGAR |
| 2023-08-02 | 0000927653-23-000062 | EDGAR |
| 2023-02-02 | 0000927653-23-000017 | EDGAR |
ETF Holders
357 ETFs hold MCK
25 shown · $14.81B total exposure · 0.25% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.14% | $3.2B | — | 2026-09-30 |
| 2 | VOO Vanguard S&P 500 ETF | Vanguard | 0.15% | $2.6B | — | 2026-09-30 |
| 3 | IVV iShares Core S&P 500 ETF | iShares (BlackRock) | 0.18% | $1.6B | $886.8B | 2026-11-03 |
| 4 | SPY State Street® SPDR® S&P 500® ETF Trust | SPDR (State Street) | 0.18% | $1.4B | $804.8B | 2026-11-03 |
| 5 | VTV Vanguard Morningstar Value ETF | Vanguard | 0.38% | $948.1M | — | 2026-09-30 |
| 6 | XLV State Street® Health Care Select Sector SPDR® ETF | SPDR (State Street) | 1.75% | $857.8M | $49.1B | 2026-11-03 |
| 7 | VIG Vanguard Dividend Appreciation ETF | Vanguard | 0.44% | $563.2M | — | 2026-09-30 |
| 8 | IWF iShares Russell 1000 Growth ETF | iShares (BlackRock) | 0.34% | $413.2M | $120.5B | 2026-11-03 |
| 9 | USMV iShares MSCI USA Min Vol Factor ETF | iShares (BlackRock) | 1.48% | $356.5M | $24.5B | 2026-11-03 |
| 10 | COWZ Pacer US Cash Cows 100 ETF | Nport | 1.79% | $333.8M | — | 2026-07-31 |
| 11 | SPYM State Street® SPDR® Portfolio S&P 500® ETF | SPDR (State Street) | 0.18% | $324.5M | $181.7B | 2026-11-03 |
| 12 | VHT Vanguard Health Care ETF | Vanguard | 1.40% | $305.5M | — | 2026-09-30 |
| 13 | RWL Invesco S&P 500 Revenue ETF | Invesco | 2.27% | $235.6M | — | 2026-11-03 |
| 14 | RSP Invesco S&P 500 Equal Weight ETF | Invesco | 0.22% | $222.6M | — | 2026-11-03 |
| 15 | IVE iShares S&P 500 Value ETF | iShares (BlackRock) | 0.38% | $194.5M | $50.6B | 2026-11-03 |
| 16 | SCHG Schwab U.S. Large-Cap Growth ETF | Nport | 0.32% | $193.9M | — | 2026-05-31 |
| 17 | VONG Vanguard Russell 1000 Growth ETF | Vanguard | 0.28% | $153.3M | — | 2026-09-30 |
| 18 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.16% | $151.3M | $97.0B | 2026-11-03 |
| 19 | JEPI JPMorgan Equity Premium Income ETF | JPMorgan | 0.32% | $149.0M | $46.8B | 2026-11-04 |
| 20 | SPYV State Street® SPDR® Portfolio S&P 500® Value ETF | SPDR (State Street) | 0.38% | $148.4M | $38.6B | 2026-11-03 |
| 21 | VV Vanguard Morningstar Large-Cap ETF | Vanguard | 0.15% | $117.3M | — | 2026-09-30 |
| 22 | IUSV iShares Core S&P U.S. Value ETF | iShares (BlackRock) | 0.36% | $103.2M | $28.4B | 2026-11-03 |
| 23 | SCHX Schwab U.S. Large-Cap ETF | Nport | 0.13% | $96.5M | — | 2026-05-31 |
| 24 | VT Vanguard Total World Stock ETF | Vanguard | 0.09% | $87.0M | — | 2026-09-30 |
| 25 | DYNF iShares U.S. Equity Factor Rotation Active ETF | iShares (BlackRock) | 0.20% | $85.2M | $41.8B | 2026-11-03 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
29.34
TTM Diluted EPS
$37.25
TTM Revenue
$410.98B
TTM Net Income
$4.59B
TTM Op. Cash Flow
$6.85B
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q1 '27 | 2026-06-30 | $105.38B | $614.00M | $5.15 | $-220.00M |
| Q4 '26 | 2026-03-31 | $96.30B | $1.68B | $13.55 | $3.42B |
| Q3 '26 | 2025-12-31 | $106.16B | $1.19B | $9.63 | $1.23B |
| Q2 '26 | 2025-09-30 | $103.15B | $1.11B | $8.92 | $2.42B |
| Q1 '26 | 2025-06-30 | $97.83B | $784.00M | $6.25 | $-918.00M |
| Q4 '25 | 2025-03-31 | $90.82B | $1.26B | $9.84 | $7.75B |
| Q3 '25 | 2024-12-31 | $95.29B | $879.00M | $6.98 | $-2.38B |
| Q2 '25 | 2024-09-30 | $93.65B | $241.00M | $1.87 | $2.10B |
| Q1 '25 | 2024-06-30 | $79.28B | $915.00M | $7.00 | $-1.38B |
| Q4 '24 | 2024-03-31 | $76.36B | $791.00M | $6.00 | $4.15B |
| Q3 '24 | 2023-12-31 | $80.90B | $589.00M | $4.42 | $254.00M |
| Q2 '24 | 2023-09-30 | $77.22B | $664.00M | $4.92 | $965.00M |
Q1 2027 • period ending 2026-06-30 • filed 2026-08-05
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
29.34
P/B
—
P/S
0.33
EV/EBITDA
18.18
EV/Sales
0.33
ROE
—
ROA
5.2%
Div Yield
0.34%
FCF Yield
5.11%
Debt/Equity
—
Current Ratio
—
Market Cap
$134.14B
as of 2026-11-05
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
2.30M
SI % of Float
1.97%
Days to Cover
3.07
Short Vol Ratio
49.4%
Free Float
116.53M
Float %
100.0%
Short interest 2026-10-15 • Short volume 2026-11-04 • Float 2026-08-24